Cargando…
Optimization of S. aureus dCas9 and CRISPRi Elements for a Single Adeno-Associated Virus that Targets an Endogenous Gene
The power of CRISPRi to decrease targeted gene expression for clinical applications has been inhibited by delivery challenges. Existing constructs are too large to fit within the ∼4.7 kb packaging size limitation of adeno-associated virus (AAV), the only FDA approved viral vector for clinical use. T...
Autores principales: | Backstrom, Jon R., Sheng, Jinsong, Wang, Michael C., Bernardo-Colón, Alexandra, Rex, Tonia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530248/ https://www.ncbi.nlm.nih.gov/pubmed/33024795 http://dx.doi.org/10.1016/j.omtm.2020.09.001 |
Ejemplares similares
-
dCas9 regulator to neutralize competition in CRISPRi circuits
por: Huang, Hsin-Ho, et al.
Publicado: (2021) -
Implementation of dCas9-mediated CRISPRi in the fission yeast Schizosaccharomyces pombe
por: Ishikawa, Ken, et al.
Publicado: (2021) -
A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9
por: Cui, Lun, et al.
Publicado: (2018) -
Generation of a dual edited human induced pluripotent stem cell Myl7-GFP reporter line with inducible CRISPRi/dCas9
por: Metzl-Raz, Eyal, et al.
Publicado: (2022) -
In vivo
labeling of endogenous genomic loci in
C. elegans
using CRISPR/dCas9
por: Memar, Nadin, et al.
Publicado: (2022)